Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 11, 2023

Primary Completion Date

June 1, 2025

Study Completion Date

December 31, 2025

Conditions
Intracerebral HemorrhageLow T3 SyndromeNeurocritical CareHormone Replacement Therapy
Interventions
DRUG

Euthyrox

Upon discovering low T3 or low T4 levels, administer oral levothyroxine sodium tablets daily. If accompanied by a decrease in TSH, the regimen is 100μg qd (for individuals weighing \<75kg) or 150μg qd (for individuals weighing \>75kg). If not accompanied by a decrease in TSH, the regimen is 50μg qd. However, if thyroid function does not significantly improve within 3 days of medication, the regimen is adjusted to 100μg qd. Treatment should continue until transfer out of the NICU or discharge, with a minimum duration of 7 days.

DRUG

Euthyrox

Patient will not receive the oral levothyroxine sodium tablets.

Trial Locations (1)

100730

RECRUITING

Peking union medical college hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER